Edesa Biotech, Inc.
EDSA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10,792 | $12,362 | $13,897 | $1,564 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $643 | $287 | $382 | $351 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $78 | $113 | $108 | $158 |
| Total Curr. Assets | $11,513 | $12,761 | $14,387 | $2,072 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1,978 | $2,003 | $2,028 | $2,054 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $40 | $41 | $39 | $39 |
| Total NC Assets | $2,018 | $2,044 | $2,067 | $2,092 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $13,662 | $14,805 | $16,454 | $4,164 |
| Liabilities | – | – | – | – |
| Payables | $0 | $673 | $915 | $1,900 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,079 | $0 | $0 | $0 |
| Total Curr. Liab. | $1,079 | $673 | $915 | $1,900 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $131 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $131 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,210 | $673 | $915 | $1,900 |
| Equity | – | – | – | – |
| Pref Stock | $9,260 | $9,223 | $9,186 | $981 |
| Common Stock | $54,515 | $54,271 | $54,271 | $47,562 |
| Retained Earnings | -$65,911 | -$63,645 | -$61,859 | -$60,232 |
| AOCI | -$166 | -$123 | -$288 | -$224 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $12,452 | $14,132 | $15,540 | $2,264 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $13,662 | $14,805 | $16,454 | $4,164 |
| Net Debt | -$10,792 | -$12,362 | -$13,897 | -$1,564 |